| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d33814cca54d7706969c162911d2eb14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d595ec481a2a081fed4aa2fd4ff52d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_985d6440f6649fff2b079691dff467c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24a2f39aa4959b6d08d89d86d9cfabd8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1761 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate |
2008-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dc1fb2d20b1ebb8f38a24f1eef7de15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5429447f05134857f44bd712c28d5a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb255027a9e91cca47111a5b35770d92 |
| publicationDate |
2009-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009032693-A2 |
| titleOfInvention |
Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| abstract |
The present invention relates to methods of using synthetic peptides mimicking apolipoprotein E (Apo E). The invention also provides methods of using apolipoprotein E (Apo E) -mediated peptides to lower plasma glucose. The present invention also provides methods of using Apolipoprotein E-mimicking peptides (Apo E) described herein for the treatment of diabetes and diabetic complications. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9241976-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010121014-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103910802-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2751126-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2751126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014219974-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10227387-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10208103-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10653747-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9422363-B2 |
| priorityDate |
2007-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |